Merge Labs has emerged from stealth with $252 million in funding from OpenAI and others. It aims to use ultrasound to read ...

A large multicenter clinical trial led by King's College London with 150 children and adolescents has shown that a device cleared by the US FDA to treat ADHD is not effective in reducing symptoms.

Elixir Medical's DynamX Bioadaptor restores natural artery function, reducing the risk of future cardiac events.

Brain–computer interfaces have long been associated with medical labs, invasive implants, and distant promises. At CES 2026, ...

LAS VEGAS, Jan. 12, 2026 /PRNewswire/ -- LumiMind, a next-generation neurotechnology company advancing non-invasive brain health solutions, today announced that it has won the SPEED AWARD at CES 2026 ...

Brain–computer interfaces have been talked about for decades, but they’ve rarely felt practical for everyday users. At CES ...

The LumiSleep launch took place at CES 2026 in Las Vegas, where LumiMind hosted live product demonstrations at its booth ...

LumiMind, a next-generation neurotechnology company pioneering non-invasive, real-time neural modulation, will ...

LumiSleep headphones debuted at CES 2026, are a cutting-edge sleep tech that responds to the brain’s Sleep Onset Pattern for ...

Auricular vagal neuromodulation therapy is a non-invasive and non-surgical treatment that could aid cardiovascular disease ...